The lasting impact of COVID-19: autonomic dysfunctions and their implications for future healthcare

The prevalence of autonomic dysfunction, including postural orthostatic tachycardia syndrome (POTS), in patients with long COVID is significant. Studies have shown that a high proportion of long COVID patients develop POTS, with symptoms such as tachycardia, orthostatic intolerance, fatigue, and cognitive impairment. Autonomic testing in long COVID patients revealed that a considerable number exhibited autonomic dysfunction, with some showing abnormal results affecting parasympathetic cardiac function. Additionally, the majority of long COVID patients did not display specific evidence of POTS or other clear autonomic dysfunction, with only a small percentage meeting the criteria for POTS diagnosis. These findings highlight the importance of evaluating autonomic symptoms and dysfunction, including POTS, in patients with long COVID to guide appropriate management strategies for improved health outcomes.